Automated description from the Alliance of Genome Resources
Predicted to have RNA polymerase II activating transcription factor binding activity; RNA polymerase II regulatory region DNA binding activity; and promoter-specific chromatin binding activity. Predicted to be involved in several processes, including negative regulation of G1/S transition of mitotic cell cycle; negative regulation of gene expression; and regulation of lipid kinase activity. Localizes to the nucleus and transcription factor complex. Is expressed in several structures, including arm; genitourinary system; liver; retina; and spleen. Orthologous to human RBL2 (RB transcriptional corepressor like 2).